Jie Xiong Selected Research

Collagen

1/2021	Yes-Associated Protein is Involved in Myocardial Fibrosis in Rats with Diabetic Cardiomyopathy.
1/2020	Feasibility between Bifidobacteria Targeting and Changes in the Acoustic Environment of tumor Tissue for Synergistic HIFU.
9/2019	[Effect of Bifidobacterium-induced changes in tumor tissue acoustic properties on efficacy of high-intensity focused ultrasound ablation].
6/2016	Adult Stem Cells Seeded on Electrospinning Silk Fibroin Nanofiberous Scaffold Enhance Wound Repair and Regeneration.
2/2015	Silk fibroin/gelatin electrospun nanofibrous dressing functionalized with astragaloside IV induces healing and anti-scar effects on burn wound.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie Xiong Research Topics

Disease

68	Neoplasms (Cancer) 01/2022 - 03/2007
9	Inflammation (Inflammations) 01/2022 - 02/2013
8	Neoplasm Metastasis (Metastasis) 12/2021 - 02/2013
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 12/2011
7	Lymphoma (Lymphomas) 01/2022 - 06/2012
7	Fibrosis (Cirrhosis) 01/2022 - 01/2012
6	Lung Neoplasms (Lung Cancer) 12/2021 - 02/2017
6	Infections 03/2021 - 01/2016
6	Carcinogenesis 01/2021 - 10/2014
6	Necrosis 01/2020 - 09/2009
6	Pancreatitis 01/2017 - 01/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
5	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2016
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 04/2017
4	Wounds and Injuries (Trauma) 01/2021 - 01/2014
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2008
4	Diabetic Cardiomyopathies 01/2021 - 01/2019
4	Glioblastoma (Glioblastoma Multiforme) 02/2019 - 01/2013
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019 - 01/2013
4	Stomach Neoplasms (Stomach Cancer) 01/2017 - 02/2013
3	Non-alcoholic Fatty Liver Disease 01/2022 - 09/2021
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2020 - 02/2018
3	Disease Progression 01/2020 - 12/2018
3	Seizures (Absence Seizure) 11/2016 - 04/2006
3	Leukemia 04/2016 - 08/2008
3	Burns 02/2015 - 10/2005
2	Cough 06/2022 - 01/2021
2	Fever (Fevers) 06/2022 - 01/2021
2	Body Weight (Weight, Body) 01/2022 - 09/2021
2	Lymphopenia (Lymphocytopenia) 01/2022 - 01/2021
2	Obesity 01/2022 - 01/2012
2	Cognitive Dysfunction 01/2022 - 12/2019
2	Adenocarcinoma of Lung 03/2021 - 01/2018
2	Hyperglycemia 01/2021 - 01/2019
2	Hypoxia (Hypoxemia) 01/2021 - 07/2015
2	Glioma (Gliomas) 01/2021 - 03/2007
2	Acute Lung Injury 01/2021 - 01/2020
2	Critical Illness (Critically Ill) 01/2021 - 11/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 11/2016
2	Adenocarcinoma 01/2021 - 12/2016
2	Hemolysis 11/2020 - 10/2015
2	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2020 - 07/2013

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 03/2021 - 04/2011
15	MicroRNAs (MicroRNA)IBA 08/2021 - 01/2013
11	Messenger RNA (mRNA)IBA 03/2021 - 08/2008
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
8	Pharmaceutical PreparationsIBA 01/2022 - 12/2011
8	EnzymesIBA 01/2022 - 09/2009
8	Biological ProductsIBA 10/2021 - 02/2016
8	Therapeutic UsesIBA 01/2021 - 04/2008
7	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2015
7	CytokinesIBA 11/2020 - 04/2006
7	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2012 - 03/2007
6	Small Interfering RNA (siRNA)IBA 01/2021 - 02/2013
6	LigandsIBA 11/2020 - 12/2011
5	Prorenin ReceptorIBA 01/2021 - 01/2019
5	CollagenIBA 01/2021 - 02/2015
5	Interleukin-6 (Interleukin 6)IBA 11/2020 - 02/2013
4	LipopolysaccharidesIBA 01/2022 - 01/2017
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 02/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2007
3	Insulin (Novolin)FDA Link 01/2022 - 01/2019
3	Long Noncoding RNAIBA 02/2021 - 04/2017
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020 - 01/2016
3	Sulfalene (Longum)IBA 01/2020 - 01/2019
3	SuspensionsIBA 01/2020 - 07/2013
3	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 10/2018
3	ChemokinesIBA 10/2017 - 02/2013
3	Chemokine ReceptorsIBA 02/2017 - 02/2016
3	CeruletideIBA 01/2017 - 01/2013
3	Horseradish PeroxidaseIBA 04/2011 - 09/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 02/2017
2	AutoantibodiesIBA 01/2022 - 01/2020
2	Asparaginase (Elspar)FDA Link 01/2022 - 10/2021
2	LipidsIBA 01/2022 - 01/2022
2	CalciumIBA 01/2022 - 01/2022
2	Phosphorus (Red Phosphorus)IBA 01/2022 - 12/2021
2	Polylactic Acid-Polyglycolic Acid CopolymerIBA 12/2021 - 01/2019
2	Glutathione (Reduced Glutathione)IBA 10/2021 - 01/2014
2	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 01/2021
2	Histones (Histone)IBA 01/2021 - 01/2020
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2021 - 01/2020
2	LuciferasesIBA 01/2021 - 04/2011
2	Histone DemethylasesIBA 01/2021 - 08/2020
2	Nucleic AcidsIBA 01/2021 - 11/2020
2	Transcription Factors (Transcription Factor)IBA 11/2020 - 01/2020
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2020 - 01/2018
2	Environmental Pollutants (Pollutants, Environmental)IBA 11/2020 - 01/2014
2	LuteolinIBA 10/2020 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020 - 12/2011
2	Lysine (L-Lysine)FDA Link 08/2020 - 01/2020
2	Indicators and Reagents (Reagents)IBA 02/2020 - 10/2017
2	Heme Oxygenase-1IBA 01/2020 - 01/2020

Therapy/Procedure

25	Therapeutics 01/2022 - 09/2009
10	Radiotherapy 02/2019 - 03/2007
7	Drug Therapy (Chemotherapy) 03/2020 - 11/2016
3	Aftercare (After-Treatment) 06/2022 - 01/2020
2	Immunotherapy 01/2022 - 06/2012
2	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 05/2018